Action of naloxone on gender-dependent analgesic and antianalgesic effects of nalbuphine in humans
- 1 January 2000
- journal article
- Published by Elsevier in The Journal of Pain
- Vol. 1 (2) , 122-127
- https://doi.org/10.1016/s1526-5900(00)90097-x
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative painPain, 1999
- Dynorphin A increases substance P release from trigeminal primary afferent C-fibersEuropean Journal of Pharmacology, 1999
- Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptorsPAIN®, 1997
- Kappa–opioids produce significantly greater analgesia in women than in menNature Medicine, 1996
- Gender difference in analgesic response to the kappa-opioid pentazocineNeuroscience Letters, 1996
- Enhancement of morphine analgesia by the GABAB agonist baclofenNeuroscience, 1995
- Antagonistic effects of the selective, competitive N-methyl-d-aspartate (NMDA) receptor antagonist, NPC 12626, on kappa opiate-induced analgesia in male deer miceBrain Research, 1994
- A Study of the Analgesic Interaction between Intrathecal Morphine and Subcutaneous Nalbuphine in the RatAnesthesiology, 1989
- Potentiation of pentazocine analgesia by low-dose naloxone.Journal of Clinical Investigation, 1988
- Influence of the method of drug administration on analgesic responseNature, 1984